Search Results - "Volberg, Marlo"
-
1
Validation and utility of the PhysioTel™ Digital M11 telemetry implant for cardiovascular data evaluation in cynomolgus monkeys and Beagle dogs
Published in Journal of pharmacological and toxicological methods (01-05-2016)“…The cardiovascular liability of candidate compounds can be evaluated by a number of methods including implanted telemetry, jacketed telemetry and surface lead…”
Get full text
Journal Article -
2
-
3
Impact of Mrp2 on the biliary excretion and intestinal absorption of furosemide, probenecid, and methotrexate using Eisai hyperbilirubinemic rats
Published in Pharmaceutical research (2003)“…This study assesses the impact of rat multidrug resistance-associated protein 2 (Mrp2) on the biliary excretion and oral absorption of furosemide, probenecid,…”
Get full text
Journal Article -
4
Age‐related Changes in Marmoset Trabecular and Cortical Bone and Response to Alendronate Therapy Resemble Human Bone Physiology and Architecture
Published in Anatomical record (Hoboken, N.J. : 2007) (01-08-2007)“…In older humans, bone elongation ceases, periosteal expansion continues, and bone remodeling remains a dominant metabolic process. An appropriate animal model…”
Get full text
Journal Article -
5
Validation of combined toxicology and cardiovascular safety pharmacology studies using JET technology
Published in Journal of pharmacological and toxicological methods (01-07-2011)Get full text
Journal Article -
6
Zaprinast, but not dipyridamole, reverses hemodynamic tolerance to nitroglycerin in vivo
Published in European journal of pharmacology (10-10-1996)“…Hemodynamic tolerance to nitroglycerin was developed in spontaneously hypertensive rats following 2–3 days of pretreatment with 100 mg/kg of nitroglycerin…”
Get full text
Journal Article -
7
Lack of cross-tolerance between nitroglycerin and endothelium-derived relaxing factor-mediated vasoactive agents in spontaneously hypertensive rats
Published in European journal of pharmacology (30-03-1993)“…The purpose of this study was to determine whether cross-tolerance develops between nitroglycerin and endothelium-derived relaxing factor (EDRF)-mediated…”
Get more information
Journal Article -
8
Reversal or nitroglycerin tolerance by the cGMP phosphodiesterase inhibitor zaprinast
Published in European journal of pharmacology (18-06-1991)Get more information
Journal Article